×
Pieris Pharmaceuticals EBIT 2014-2024 | PVLA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Pieris Pharmaceuticals ebit from 2014 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Pieris Pharmaceuticals EBIT 2014-2024 | PVLA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Pieris Pharmaceuticals ebit from 2014 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
NPK (NPKI)
$626M
Performant Healthcare (PHLT)
$245M
FTAC Emerald Acquisition (FLDD)
$158M
Swiftmerge Acquisition (ANNA)
$42M
Insight Acquisition (AMOD)
$23M
Hanryu Holdings (GITS)
$17M
LQR House (YHC)
$11M
ATIF Holdings (ZBAI)
$9M
Lion Electric (LEVGQ)
$0M